Nonmyeloablative pentostatin-cyclophosphamide preconditioning improves rates of engraftment in adults undergoing haploidentical HCT for sickle cell disease. - Limerick E; Hsieh M; Queen J; Grecco ML; Varga J; Brooks J; Coles W; Jeffries N; Fitzhugh CD (PloS one, 2026)